L. Barefoot

1.1k total citations
13 papers, 777 citations indexed

About

L. Barefoot is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, L. Barefoot has authored 13 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in L. Barefoot's work include Clostridium difficile and Clostridium perfringens research (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). L. Barefoot is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). L. Barefoot collaborates with scholars based in United States and China. L. Barefoot's co-authors include David R. Snydman, Robin Ruthazer, José Antônio Baddini Martínez, Yoav Golan, Stanley A. Nasraway, Padade M. Vue, Christopher H. Schmid, Marci Drees, Paul C. Stark and Esin Şenol and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Investigative Dermatology and Journal of General Internal Medicine.

In The Last Decade

L. Barefoot

13 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Barefoot United States 10 461 167 149 120 119 13 777
Donald J. Lyon Hong Kong 18 409 0.9× 272 1.6× 101 0.7× 178 1.5× 135 1.1× 34 940
Marian Matushek United States 7 571 1.2× 216 1.3× 104 0.7× 82 0.7× 287 2.4× 10 961
Chun-Ming Lee Taiwan 16 238 0.5× 244 1.5× 71 0.5× 151 1.3× 54 0.5× 32 846
David Rubenstein United States 10 310 0.7× 151 0.9× 72 0.5× 70 0.6× 120 1.0× 20 756
I.K. Hosein United Kingdom 16 326 0.7× 103 0.6× 118 0.8× 54 0.5× 105 0.9× 35 617
Donald Blom United States 7 564 1.2× 104 0.6× 240 1.6× 44 0.4× 107 0.9× 8 797
Louise‐Marie Dembry United States 17 383 0.8× 383 2.3× 111 0.7× 51 0.4× 111 0.9× 35 982
Stefanie Kampmeier Germany 15 342 0.7× 141 0.8× 79 0.5× 87 0.7× 144 1.2× 52 757
R.C. Spencer United Kingdom 18 212 0.5× 467 2.8× 156 1.0× 115 1.0× 134 1.1× 46 1.1k
Louise M. Dembry United States 15 606 1.3× 427 2.6× 62 0.4× 54 0.5× 148 1.2× 36 958

Countries citing papers authored by L. Barefoot

Since Specialization
Citations

This map shows the geographic impact of L. Barefoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Barefoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Barefoot more than expected).

Fields of papers citing papers by L. Barefoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Barefoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Barefoot. The network helps show where L. Barefoot may publish in the future.

Co-authorship network of co-authors of L. Barefoot

This figure shows the co-authorship network connecting the top 25 collaborators of L. Barefoot. A scholar is included among the top collaborators of L. Barefoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Barefoot. L. Barefoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Barefoot, L., et al.. (2018). 496 RXI-109 treatment to reduce the formation of hypertrophic dermal scars. Journal of Investigative Dermatology. 138(5). S84–S84. 1 indexed citations
2.
Drees, Marci, David R. Snydman, Christopher H. Schmid, et al.. (2008). Antibiotic Exposure and Room Contamination Among Patients Colonized With Vancomycin-Resistant Enterococci. Infection Control and Hospital Epidemiology. 29(8). 709–715. 33 indexed citations
3.
Drees, Marci, David R. Snydman, Christopher H. Schmid, et al.. (2008). Prior Environmental Contamination Increases the Risk of Acquisition of Vancomycin-Resistant Enterococci. Clinical Infectious Diseases. 46(5). 678–685. 216 indexed citations
4.
Golan, Yoav, Shira Doron, John Griffith, et al.. (2006). The Impact of Gown-Use Requirement on Hand Hygiene Compliance. Clinical Infectious Diseases. 42(3). 370–376. 46 indexed citations
5.
Ruthazer, Robin, Richard B. Freeman, Michael Angelis, et al.. (2005). Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transplantation. 11(12). 1597–1602. 31 indexed citations
6.
Muñoz-Price, L. Silvia, Malcolm Slifkin, Robin Ruthazer, et al.. (2004). The Clinical Impact of Ganciclovir Prophylaxis on the Occurrence of Bacteremia in Orthotopic Liver Transplant Recipients. Clinical Infectious Diseases. 39(9). 1293–1299. 53 indexed citations
7.
Martínez, José Antônio Baddini, et al.. (2003). Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit. Archives of Internal Medicine. 163(16). 1905–1905. 167 indexed citations
8.
Şenol, Esin, Jeffrey A. DesJardin, Paul C. Stark, L. Barefoot, & David R. Snydman. (2002). Attributable Mortality ofStenotrophomonas maltophiliaBacteremia. Clinical Infectious Diseases. 34(12). 1653–1656. 108 indexed citations
9.
Supran, Stacey, et al.. (1999). NEORAL IS ASSOCIATED WITH LESS NEUROTOXICITY AFTER LIVER TRANSPLANTATION. Transplantation. 67(7). S191–S191. 2 indexed citations
10.
Nathan, Catherine, et al.. (1998). Utility of Serial Rectal Swab Cultures for Detection of Ceftazidime- and Imipenem-Resistant Gram-Negative Bacilli from Patients in the Intensive Care Unit. European Journal of Clinical Microbiology & Infectious Diseases. 17(10). 727–730. 7 indexed citations
11.
Katz, David A., David W. Bates, Eve Rittenberg, et al.. (1997). Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea. Journal of General Internal Medicine. 12(1). 57–62. 20 indexed citations
12.
Katz, David A., David W. Bates, Eve Rittenberg, et al.. (1997). Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea. Journal of General Internal Medicine. 12(1). 57–62. 16 indexed citations
13.
Falagas, Matthew E., et al.. (1996). Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. European Journal of Clinical Microbiology & Infectious Diseases. 15(12). 913–921. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026